Clinical trial
Regulation of the Immune System in Response to the Treatment With Tocilizumab in RA Patients
NCT01633346 is registered in ClinicalTrials.gov with Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Regulation of the Immune System in Response to the Treatment With Tocilizumab in RA Patients
- Lead sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2010
- Completion date
- November 30, 2016
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis